Multiple Dosing
Multiple Dosing - Related Videos
01:25
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
0 Views •
2025
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:11
Bioavailability Study Design: Single Versus Multiple Dose Studies
0 Views •
2025
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:21
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
0 Views •
2025
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:24
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
0 Views •
2025
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
0 Views •
2025
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
FAQs
Accumulation occurs when the dosing interval is shorter than the drug’s effective elimination period. Residual drug remains present when the next dose is administered, so successive doses contribute to rising exposure. This increase does not continue indefinitely; concentrations eventually reach steady state, a condition that helps characterize the expected ongoing exposure during treatment.
These pharmacokinetic factors determine how drug concentrations change between administrations. Half-life describes the drug’s elimination behavior, while dose size and dosing interval shape the magnitude and timing of concentration rises and falls. Considering them together helps pharmacologists design regimens that support therapeutic exposure while limiting the potential for excessive drug accumulation.
Each administration produces a new concentration increase, followed by distribution and elimination that reduce drug levels before the next dose. The resulting rise-and-fall pattern reflects absorption, distribution, metabolism, and elimination. Under a repeated regimen, examining these fluctuations helps explain how treatment maintains exposure over time and why the timing of doses matters.
Steady state provides a reference point for the exposure produced by an ongoing regimen after accumulation has occurred. It allows the expected concentration pattern during continued treatment to be considered rather than evaluating doses in isolation. This is particularly relevant when pharmacologists assess whether a regimen can sustain therapeutic effects over the intended treatment period.
Regimen design begins with the drug’s pharmacokinetic characteristics, especially its half-life, dose size, and effective elimination period. Researchers then select defined administration intervals that account for how rapidly concentrations change and whether accumulation is expected. The resulting schedule is evaluated in relation to therapeutic exposure, potential toxicity, and the need for sustained treatment.
Repeated administration is useful when treatment requires drug effects or exposure to continue over time rather than follow a single administration. It therefore supports chronic therapies and provides a framework for evaluating sustained efficacy and toxicity. Pharmacologists also use the approach to guide monitoring and dose adjustment when patient treatment requires ongoing control of drug exposure.